April 15th, 2021 Coherent Market Insights Releases
SEATTLE, April 15, 2021, (MEDGADGET) — The process of drawing blood from veins is known as phlebotomy. The procedure, also known as venipuncture, is primarily performed by specialists called phlebotomists. Medical laboratory scientists, doctors, and nurses often perform phlebotomy process. Phlebotomy is carried out for blood donations, medical testing, and research. Light blue top tubes are used for performing coagulation tests. Blood clotting or coagulation is the method by which blood changes into a lump known as clot.
Get Exclusive Sample Copy of “Light blue tube Phlebotomy Market” Report – https://www.coherentmarketinsights.com/insight/request-sample/143
This process leads to hemostasis, and prevent blood loss from the body. The course of action of coagulation includes activation, bonding, and accumulation of platelets in addition to deposition and development of fibrin. Disorder related to clotting can result in thrombosis or hemorrhage. Phlebotomy tubes with light blue stoppers primarily contain two additives: sodium citrate (3.2% or 3.8%) and Citrate, theophylline, adenosine, dipyridamole) or CTAD. The citrate acts as an anticoagulant. It binds the calcium present in the blood that is required for clotting. As the additive gives a whole blood sample that is plasma and red blood cells, the light blue phlebotomy tubes have buffered tri-sodium citrate solution as well.
Various tests are performed using the light blue phlebotomy tube such as partial thromboplastin time (PTT), fibrin degradation products (FDP), thrombin time (TT), prothrombin time (PT), Fibrinogen, and D-dimer. The global light blue tube phlebotomy market is expected to witness significant growth over the forecast period. Rising health awareness among populace has resulted in increasing blood diagnostic tests; particularly coagulation tests, owing to rising incidences of low platelet count, increasing prevalence of liver diseases, as well as rising surgeries are the factors that is expected to drive growth of light blue tube phlebotomy market over the forecast period.
Light Blue Tube Phlebotomy Market Taxonomy
On the basis of type of end-user, the global light blue tube phlebotomy market is classified into:
An important factor for using light blue top tubes is the amount of blood extracted in the tubes. The tubes should be filled to the brim for obtaining accurate results. The blood should continue to flow from the patient’s body into the tube until the tube is full and the blood flow ceases. If the blood is extracted through a syringe, the optimum level (as marked in most of the light blue top tubes) should be maintained. This factor is important because light blue top tubes are used for coagulation tests which require 9:1 blood to anticoagulant ratio.
Order a copy of Light blue tube Phlebotomy Market Report 2021 @ https://www.coherentmarketinsights.com/insight/buy-now/143
Asia Pacific is expected to be growth engine for global light blue tube phlebotomy market
Increasing incidence of blood related diseases is expected to create a highly conducive environment for growth of the global light blue tube phlebotomy market. For instance, according to the Center for Disease Control and Prevention, almost 1 to 2 people are affected by DVT/PE. Pulmonary embolism (PE) typically occurs when a blood clot known as a deep vein thrombosis (DVT), habitually in the leg, moves to the lungs and form a lump, thereby blocking a blood vessel. It results into to low oxygen levels in the blood. It can harm the lung and may cause heart failure as well. Therefore, a blood coagulation test is usually suggested to patients with a history of such diseases. In South Asia, particularly in India, the blood fibrinogen level is usually high, owing to high prevalence of CHD or coronary heart diseases and elevated levels of glycoprotein IIb/IIIa which work as a receiver for fibrinogen. Moreover, according to a report by Journal of Thrombosis and Hemostatis, there is a growing emphasis upon the requirement of a controlled and randomized evaluation with clinical result measurement to ascertain that thromboprophylaxis (avoidance of thromboembolic disease or impediment of blood vessels by blood clot) is crucial in joint surgery in Asia. As blood coagulation tests are generally recommended before and after a surgery, escalation in the number of surgeries around the world is expected fuel the light blue tube phlebotomy market growth during the forecast period.
Key players in the global light blue tube phlebotomy market
Some of the major players operating in the global light blue tube phlebotomy market include Greiner BioOne, Medical Expo, CML Biotech Pvt. Ltd., Ajosha BioTeklik Pvt. Ltd., New MicroMed International Pvt. Ltd., FL Medical, Gosselin, and Advacare Pharma.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com United States of America: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050-5539-1737 India: +91-848-285-0837
Sign up and submit a press release
Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.